Glycated apolipoprotein A-I assay by combination of affinity chromatography and latex immunoagglutination

Annals of Clinical Biochemistry

Volumn 37, Issue 4, 2000, Pages 498-506

  Shishino, Koji ^a   Murase, Mitsuharu ^a   Makino, Hideichi ^a   Saheki, Shuichi ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BORONIC ACID DERIVATIVE; GLUCOSE; LATEX;

AFFINITY CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GEL FILTRATION; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; IMMUNOASSAY; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE VALUE; TURBIDIMETRY;

AGGLUTINATION; APOLIPOPROTEIN A-I; BLOOD GLUCOSE; BORONIC ACIDS; CASE-CONTROL STUDIES; CHEMISTRY, CLINICAL; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, GEL; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOASSAY; MALE; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TIME FACTORS;

EID: 0033933008     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456320003700411     Document Type: Article

References (33)

1. Kim HJ, Kurup IV. Nonenzymatic glycosylation of human plasma low density lipoprotein. Evidence for in vitro and in vivo glycosylation. Metabolism 1982; 31: 348-53
2. Gonen B, Baenziger J, Schonfeld G, Jacobson D, Farrar P. Nonenzymatic glycosylation of low density lipoproteins in vivo. Effects on cell-interactive properties. Diabetes 1981; 30: 875-8
3. Shishino K, Saheki S, Takeuchi N. Glycated apo B protein and vascular complications in diabetes mellitus. Jpn J Clin Chein 1995; 24: 74-81
4. Witzum JL, Mahoney EM, Braks MJ. Nonenzymatic glycosylation of low density lipoprotein alters its biologic activity. Diabetes 1982; 31: 28391
5. Tames FJ, Mackness MI, Arrol S, Laing I, Durrington PN. Nonenzymatic glycation of apoprotein B in sera of diabetes and non-diabetic subjects. Atherosclerosis 1992; 93: 237-44
6. Yoshimine N, Tateishi T. Determination of serum lipid peroxide using lO-W-methylcarbamoyl-S,?dimethylamino-10-//-phenothiazine (MCDP) with special reference to aging and disease. Jpn J Clin Palhol 1989; 37: 975-9
7. Andrews B, Burnand K, Paganga G, Browse N, Rice-Evans C, Sommerville K, et al. Oxidizability of low density lipoproteins in patients with carotid artery atherosclerosis. Atherosclerosis 1995; 112: 77-84
8. Akasaka K, Ohrui H, Meguro H. Measurement of cholesterol ester hydroperoxides of high and combined low and very low density lipoprotein in human plasma. Biosci Bioteclmol Kochern 1994; 58: 396-9
9. Tateishi T, Yoshimine N, Kuzuya F. Serum lipid peroxide lipoprotein fractions by a new method. J Jpn Atheroscler Soc 1988; 15: 1585-6
10. Hahn M, Subbiah MTR. Significant association of lipid peroxidation products with high density lipoproteins. Biochem Mol Biol Int 1994; 33: 699-704
11. Morio H, Saito H, Hirai A, Tamura Y, Yoshida S. Effects of modified LDL on the release of NO and PGh from rat peritoneal macrophages. J Atheroscler Thromb 1995; 2: 41-5
12. Shishino K, Saheki S, Kenji T, Murase M, Takeuchi N. Measurement of lipid peroxides in apo B-containing lipoprotein fraction in plasma. Jpn J Clin Cliem 1996; 25: 157-64
13. Tertov VV, Sobenin IA, Orekhov AN. Modified (desialated) low-density lipoprotein measured in serum by lectin-sorbent assay. Clin Client 1995; 41: 1018-21
14. Bucala R, Marita Z, Koscinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation HI vitro. Proc Natl AcadSci USA 1993; 90: 6434-8
15. Lindergren FT, Elliott HA, Gofmann JW. The ultracentrifugal characterization and isolation of human blood lipids and lipoproteins with applications to the study of atherosclerosis. J Phys Colloid Chem 1951; 55: 80-93
16. Adams GH, Scumaker VH. Polydispersity of human low density lipoproteins. Ann N Y Acad Sci 1969; 164: 130-43
17. Krauss RM, Brake DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982; 23: 97-104
18. Fisher WR. Heterogeneity of plasma low density lipoproteins manifestation of the physiologic phenomenon in man. Metabolism 1983; 32: 283-91
19. Shishino K, Saheki S, Takeuchi N. Separation of LDL subclasses by non-denaturing polyacrylamide slab gel electrophoresis and distribution of the subclasses in hyperlipidemias. J Anal Bio Sei 1995; 18: 96-101
20. Curtiss LK, Witztum JL. Plasma apolipoproteins A-I, All, B, CI and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 1985; 34: 452-61
21. 3 determined in serum by discontinuous gradient gel electrophoresis. Clin Chem 1991; 37: 1149-52
22. Puchois P, Kandoussi A, Fievet P, Fourrier JL, Bertrand M, Korren E, et al. Apolipoprotein A-lcontaining lipoproteins in coronary artery disease. Atherosclerosis 1987; 68: 35-40
23. Calvo C, Talussot C, Ponsin G, Berthezene F. Non enzymatic glycation of apolipoprotein A-I. Effects on its self-association and lipid binding properties. Biochem Biophys Res Commun 1988; 153: 1060-70
24. Kobayashi K, Ogasahara N, Sakaguchi T, Kimura M, Taniuchi K, Matsuoka A. Agarose gel electrophoresis with nitroblue tetrazolium coloration for determination of glycated lipoproteins in serum from diabetics. Clin Chem 1990; 36: 65-9
25. Steinbrecher UP, Witztum JL, Kesaniemi YA, Elam RL. Comparison of glycosylated low density lipoprotein with methylated or cyclohexanedionetreated low density lipoprotein in the measurement of receptor-independent low density lipoprotein catabolism. J Clin Invest 1983; 71: 960-4
26. Sakai J, Cottam GL. Glycosylation of LDL decreases its ability to interact with high affinity receptors of human fibroblasts in \itro and decreases its clearance from rabbit plasma in vivo. Biochim Biophys Ada 1982; 713: 199-207
27. Goldstein JL, Ho TK, Basu SK, Brown MS. Binding site on macrophages that mediate uptake and degradation of acetyl low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sei USA 1979; 76: 333-7
28. Heinecke J.V. Free radical modification of low density lipoprotein, mechanisms and biochemical consequences. Free Radie Biol A fed 1987; 3: 65-73
29. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity. N Engl J A fed 1989; 320: 915-24
30. Duell PB, Oram JF, Bierman EL. Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux. Diabetes 1991; 40: 377-84
31. Calvo C, Verdugo C. Association in vivo of glycated apolipoprotein A-l with high density lipoproteins. Eiir J Clin Chem Clin Biochem 1992; 30: 3-5
32. Fournier N, Myara I, Alger V, Moatti N. Reactivity of lecithin-cholesterol acyl transferase (LCAT) toward glycated high-density lipoproteins (HDL). Clin Cliim Acta 1995; 234: 47-61
33. Jack CM, Sheridan B, Kennedy L, Stout RW. Nonenzymatic glycosylation of low-density lipoprotein. Results of affinity chromatography method. Diabetologia 1988; 31: 126-8